Diane J Burgess Selected Research

Polylactic Acid-Polyglycolic Acid Copolymer

1/2021	Sterilization of Drug-Loaded Composite Coatings for Implantable Glucose Biosensors.
11/2018	PLGA microsphere/PVA hydrogel coatings suppress the foreign body reaction for 6 months.
9/2015	Multiple tissue response modifiers to promote angiogenesis and prevent the foreign body reaction around subcutaneous implants.
2/2014	Microspheres prepared with PLGA blends for delivery of dexamethasone for implantable medical devices.
8/2013	Polymeric "smart" coatings to prevent foreign body response to implantable biosensors.
2/2013	A miniaturized transcutaneous system for continuous glucose monitoring.
11/2012	Effect of dexamethasone-loaded poly(lactic-co-glycolic acid) microsphere/poly(vinyl alcohol) hydrogel composite coatings on the basic characteristics of implantable glucose sensors.
12/2004	Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation control.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diane J Burgess Research Topics

Disease

16	Inflammation (Inflammations) 01/2022 - 12/2004
9	Foreign-Body Reaction 01/2022 - 01/2007
9	Foreign Bodies (Foreign Body) 01/2022 - 01/2010
8	Fibrosis (Cirrhosis) 09/2015 - 12/2004
7	Neoplasms (Cancer) 05/2022 - 01/2015
4	Breast Neoplasms (Breast Cancer) 01/2015 - 07/2012
3	Pain (Aches) 02/2021 - 04/2018
2	Stomatitis 02/2021 - 04/2020
2	Anaphylaxis (Anaphylactic Shock) 01/2020 - 10/2019
1	Chronic Disease (Chronic Diseases) 10/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2021
1	Glioma (Gliomas) 12/2019
1	Hypersensitivity (Allergy) 10/2019
1	Knee Injuries (Knee Injury) 04/2018
1	Knee Osteoarthritis 04/2018
1	Osteoarthritis 04/2018
1	Ischemia 10/2016
1	Wounds and Injuries (Trauma) 08/2015
1	Disease Progression 04/2005

Drug/Important Bio-Agent (IBA)

17	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 12/2004
13	Pharmaceutical PreparationsIBA 05/2022 - 12/2004
9	HydrogelsIBA 01/2021 - 12/2004
8	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2021 - 12/2004
7	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2011
6	Liposomes (Liposome)IBA 05/2022 - 07/2012
4	LipidsIBA 05/2022 - 07/2012
4	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2018 - 01/2007
3	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2022 - 01/2007
3	CollagenIBA 10/2021 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015 - 01/2007
2	SolutionsIBA 01/2022 - 01/2010
2	Polyvinyl AlcoholIBA 01/2021 - 02/2013
2	Biological ProductsIBA 11/2020 - 04/2005
2	cyclic arginine-glycine-aspartic acid peptideIBA 01/2020 - 10/2019
2	Peptides (Polypeptides)IBA 01/2020 - 12/2019
2	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2015
2	Small Interfering RNA (siRNA)IBA 04/2013 - 07/2012
2	CalciumIBA 08/2012 - 07/2012
1	Insulin (Novolin)FDA Link 10/2021
1	Blood Glucose (Blood Sugar)IBA 10/2021
1	Amyloid (Amyloid Fibrils)IBA 10/2021
1	Dosage Forms (Dosage Form)IBA 02/2021
1	GelsIBA 02/2021
1	Hormones (Hormone)IBA 09/2020
1	Linoleic Acid (Linoleate)IBA 04/2020
1	Bupivacaine (Bupivacaine Hydrochloride)FDA LinkGeneric 04/2020
1	Drug CarriersIBA 01/2020
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2020
1	MicellesIBA 01/2020
1	Serine (L-Serine)FDA Link 01/2020
1	Endoplasmic Reticulum Chaperone BiPIBA 12/2019
1	Mechanistic Target of Rapamycin Complex 2IBA 12/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2019
1	peptide E (adrenal medulla)IBA 10/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 10/2019
1	Immunoglobulin G (IgG)IBA 10/2019
1	AnaphylatoxinsIBA 10/2019
1	Immunoglobulin E (IgE)IBA 10/2019
1	CytokinesIBA 10/2019
1	SiliconIBA 11/2018
1	Saline SolutionIBA 04/2018
1	Triamcinolone Acetonide (Azmacort)FDA LinkGeneric 04/2018
1	Adenosine Diphosphate (ADP)IBA 04/2018
1	FX006IBA 04/2018
1	Levodopa (L Dopa)FDA LinkGeneric 10/2016
1	polyvinyl alcohol hydrogelIBA 09/2015
1	Capsules (Microcapsules)IBA 08/2015
1	calcium phosphateIBA 01/2015
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2015
1	Antifibrotic AgentsIBA 01/2015
1	PolymersIBA 08/2013
1	Proteoglycans (Proteoglycan)IBA 04/2013
1	Heparin (Liquaemin)FDA LinkGeneric 04/2013
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 04/2013
1	Sulfates (Sulfates, Inorganic)IBA 04/2013
1	IonsIBA 07/2012
1	1,2- dioleoyl- sn- glycero- 3- phosphoglycerol (DOPG)IBA 07/2012
1	Biocompatible Materials (Biomaterials)IBA 06/2010
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2008
1	DNA (Deoxyribonucleic Acid)IBA 04/2005

Therapy/Procedure

13	Microspheres (Microsphere) 01/2021 - 12/2004
4	Therapeutics 05/2022 - 01/2015
2	Catheters 01/2022 - 10/2021
2	Drug Therapy (Chemotherapy) 11/2020 - 12/2019
1	Immunotherapy 11/2020
1	Intravenous Injections 01/2020
1	Subcutaneous Injections 01/2020
1	Intra-Articular Injections 04/2018